Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

7.7%

21 terminated/withdrawn out of 274 trials

Success Rate

91.6%

+5.1% vs industry average

Late-Stage Pipeline

35%

96 trials in Phase 3/4

Results Transparency

73%

167 of 229 completed trials have results

Key Signals

7 recruiting167 with results13 terminated8 withdrawn

Enrollment Performance

Analytics

N/A

102(39.8%)

Phase 3

57(22.3%)

Phase 4

39(15.2%)

Phase 2

37(14.5%)

Phase 1

19(7.4%)

Early Phase 1

2(0.8%)

256Total

N/A(102)

Phase 3(57)

Phase 4(39)

Phase 2(37)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (274)

Showing 20 of 274 trials

NCT07511387Not ApplicableRecruiting

Efficacy of a Novel Myopia Defocus Spectacle Lens in School-Aged Children

Role: collaborator

NCT07168902Phase 2Recruiting

Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension

Role: lead

NCT07490535Phase 4Not Yet Recruiting

This is a Single Center, Open-label Prospective Study to Evaluate the Effect of Xiidra® (Lifitegrast Ophthalmic Solution 5.0%) on Tear Film Biomarkers in Dry Eye

Role: collaborator

NCT07128628Phase 2Recruiting

A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease

Role: lead

NCT04354545Recruiting

Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications

Role: collaborator

NCT07412496Phase 2Not Yet Recruiting

A Study to Evaluate the Use of Topical Ocular BL1332 for the Management of Postoperative Ocular Pain Following Photorefractive Keratectomy

Role: lead

NCT07377474Not ApplicableNot Yet Recruiting

A Study to Investigate the Safety and Effectiveness of the Technolas® TENEO 317 Model 2 Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Myopia or Myopic Astigmatism

Role: lead

NCT06978244Phase 1Active Not Recruiting

A Study to Assess Safety, Tolerability, and Pharmacokinetics of Ascending Concentrations of Topical Ocular BL1332 in Healthy Volunteers

Role: lead

NCT04838223Suspended

Neurosensory Abnormalities in SymptomAtic Ocular Surface Patients (NASA)

Role: collaborator

NCT05264623Not ApplicableActive Not Recruiting

Safety and Effectiveness of the TENEO 317 Model 2 (1.28 US) Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Hyperopia With or Without Astigmatism

Role: lead

NCT06060041Recruiting

IC-8 Apthera IOL New Enrollment Post Approval Study

Role: lead

NCT07054606Phase 4Completed

A Study to Evaluate Concomitant Perfluorohexyloctane Use With Contact Lens Wear

Role: lead

NCT07111013Phase 3Withdrawn

A Study to Assess the Long-Term Safety of Lifitegrast/Perfluorohexyloctane Fixed-Dose Combination in Subjects With Dry Eye Disease

Role: lead

NCT06785194Not Yet Recruiting

Revive Toric RWE Study

Role: lead

NCT06333015Not ApplicableActive Not Recruiting

Study to Evaluate the Safety and Effectiveness of the enVista® Beyond (EY) EDF Intraocular Lens in Subjects Undergoing Cataract Extraction

Role: lead

NCT06309953Phase 4Completed

A Study to Evaluate Early Treatment Outcomes With Miebo™ in Subjects With Dry Eye Disease

Role: lead

NCT05984290Not ApplicableCompleted

Study of Safety and Effectiveness of the Boston Orthokeratology Shaping Lens in the Arise Orthokeratology Lens

Role: lead

NCT07090044Phase 4Completed

Comparing Post-intravitreal Injection Pain Scores Using Loteprednol, Bromfenac Sodium, and Artificial Tears Over a 24-hour Period

Role: collaborator

NCT05126953Not ApplicableCompleted

2-Hour Dispensing Evaluation of Samfilcon A Lenses With EPG01 Packaging Solution Compared to Commercially Available B+L Ultra Lenses

Role: lead

NCT06594185Not ApplicableCompleted

A Study to Evaluate Real World Outcomes of the enVista® Aspire (EA) and Aspire Toric (ETA) Intraocular Lens in Subjects Undergoing Cataract Extraction

Role: lead